4/A: Daxor Corp CEO Michael Feldschuh Increases Stake in Company
SEC Form 4
Daxor Corp's CEO, Michael Richard Feldschuh, acquired 1,492 shares of Daxor Common Stock at $7.72 per share on March 10, 2024, increasing his direct holdings to 208,984 shares.
Summary
- On March 10, 2024, Michael Richard Feldschuh, the CEO of Daxor Corp, purchased 1,492 shares of Daxor Common Stock.
- The purchase price was $7.72 per share.
- Following this transaction, Feldschuh directly owns 208,984 shares of Daxor Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase suggests confidence, but it's a relatively small transaction.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- The CEO's increased stake could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/10/2024 | Date of transaction: Michael Feldschuh purchased 1,492 shares of Daxor Common Stock. |
| 03/11/2025 | Date of original filing (if amendment). |
| 03/20/2025 | Date of signature on the report. |
Keywords
Daxor Corp, Michael Feldschuh, Insider Trading, Stock Acquisition, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.